Sunil Singhania’s Abakkus Asset Manager Acquires 1.18 Per cent Stake in Pharma Company; Stock Surges Over 10 Per cent!
The company’s shares have delivered an impressive return of over 25 per cent in the past year.
Sunil Singhania’s Abakkus Asset Manager Private Ltd bought 10.7 lakh shares (1.18 per cent stake) in Aarti Pharmalabs Ltd via a bulk deal on December 26 at Rs 575.08. Promoter group entities Orchid Family Trust and Tulip Family Trust were the sellers.
Aarti Pharmalabs Ltd established in 2019, is a prominent manufacturer of pharmaceuticals and nutraceuticals. Formerly known as Aarti Organics, the company was founded in 1984 as a wholly owned subsidiary (WOS) of Aarti Industries Limited. In October 2022, it was demerged to operate as a separate publicly listed entity. It is globally recognized for its production of generic APIs, intermediates, and xanthine derivatives, while also providing CDMO/CMO services. The company operates six manufacturing facilities and three R&D centers.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
At the start of the day's trading session, shares of Aarti Pharmalabs Ltd opened at Rs 649.55 per share, compared to the previous day's closing figure of Rs 631.75 per share on the BSE. Currently, the shares are at Rs 683.45 per share. The company's current market capitalization stands at Rs 6,194 crore. Additionally, the company’s shares have delivered over 25 per cent multibagger return in just 1 year.
As per the Quarterly Results, in the Q2 FY25, Aarti Pharmalabs Ltd recorded a revenue of Rs 458 crore compared to Rs 440 crore. The operating profit stood at Rs 94 crore. The company reported a net profit of Rs 55 crore compared to a profit of Rs 52 crore.
Investors must keep this Small-Cap stock on their radar.
Disclaimer: The article is for informational purposes only and not investment advice.